Reuters logo
BRIEF-Avadel Pharmaceuticals Plc ‍enters into a license agreement with Serenity Pharmaceuticals Llc​
September 5, 2017 / 8:23 PM / 2 months ago

BRIEF-Avadel Pharmaceuticals Plc ‍enters into a license agreement with Serenity Pharmaceuticals Llc​

Sept 5 (Reuters) - Avadel Pharmaceuticals Plc

* Avadel Pharmaceuticals Plc - ‍entered into a license agreement with Serenity Pharmaceuticals Llc​

* Avadel Pharmaceuticals Plc - ‍deal includes $50 million upfront payment; funded by cash on hand​

* Avadel - ‍terms of agreement also include $20 million due at earlier of full scale commercial launch or June 30, 2018, performance-based milestones​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below